Serial Number 79416304
681

Registration Progress

Application Filed
Oct 11, 2024
Under Examination
Approved for Publication
Published for Opposition
Aug 19, 2025
Registered

Trademark Image

Basic Information

Serial Number
79416304
Filing Date
October 11, 2024
Published for Opposition
August 19, 2025
Drawing Code
2

Status Summary

Current Status
Active
Status Code
681
Status Date
Jul 28, 2025
Application
Pending
Classes
005

Rights Holder

Otsuka Pharmaceutical Co., Ltd.

03
Address
2-9, Kanda-Tsukasamachi,
Chiyoda-ku Tokyo 101-8535
JP

Ownership History

Otsuka Pharmaceutical Co., Ltd.

Original Applicant
03
JP

Legal Representation

Attorney
Kazuyo Morita

USPTO Deadlines

All Deadlines Cleared

All 1 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

14 events
Date Code Type Description Documents
Jul 9, 2025 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jun 27, 2025 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jun 27, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jun 27, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jun 7, 2025 RFNT P REFUSAL PROCESSED BY IB Loading...
May 20, 2025 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Loading...
May 20, 2025 RFRR P REFUSAL PROCESSED BY MPU Loading...
Mar 25, 2025 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
Mar 24, 2025 CNRT R NON-FINAL ACTION WRITTEN Loading...
Mar 21, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
Feb 17, 2025 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Feb 17, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Feb 14, 2025 LIMI I LIMITATION FROM ORIGINAL APPLICATION ENTERED Loading...
Feb 6, 2025 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of kidney diseases and disorders; pharmaceutical preparations for the treatment of immunoglobulin A nephropathy (IgAN); pharmaceutical preparations for treatment of autoimmune diseases and disorders.

Additional Information

Design Mark
The mark consists of a design consisting of connected geometric shapes with the outer most points forming the shape of a half circle. The half circle is formed by a triangle in light gray over and to the left of the design of a square formed by two joined dark gray triangles, over and to the left of the design of a red square, over and to the right of the design of a square formed by two joined dark gray square, over and to the right of a light gray triangle.
Color Claim
The color(s) light gray, dark gray and red is/are claimed as a feature of the mark.

Classification

International Classes
005